Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
51
NCT02433626
Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies
Phase: Phase 1
Role: Lead Sponsor
Start: Dec 31, 2015
Completion: Jun 30, 2020